BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jones TC. A call to restructure the drug development process: government over-regulation and non-innovative late stage (Phase III) clinical trials are major obstacles to advances in health care. Sci Eng Ethics 2005;11:575-87. [PMID: 16279756 DOI: 10.1007/s11948-005-0027-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
Number Citing Articles
1 Arnardottir AH, Haaijer-Ruskamp FM, Straus SM, Eichler HG, de Graeff PA, Mol PG. Additional safety risk to exceptionally approved drugs in Europe? Br J Clin Pharmacol 2011;72:490-9. [PMID: 21501215 DOI: 10.1111/j.1365-2125.2011.03995.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]